Search
for
Sort by
Research 241–270 of 1000+
- 176 Hair eruption initiates adverse events of EGFR-targeted cancer therapy
- Hair growth and restoration by transcriptional control of tissue regeneration in cancer recovery process by Huaier.
- Montagna Symposium 2015: Harnessing Stem Cells to Reveal Novel Skin Biology and Disease Treatments
- The role of Kindlin-1 in skin homeostasis and tumor development
- Estrogens and aging skin
- Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women’s cancers. Results of a prospective study
- Tobacco and the skin
- 329 Mechanisms of Cutaneous Adverse Events during Targeted Cancer Therapy
- Inactivation of the Vitamin D Receptor Enhances Susceptibility of Murine Skin to UV-Induced Tumorigenesis
- The 1,25-dihydroxyvitamin D3-independent actions of the vitamin D receptor in skin
- Rosmarinus officinalis and Skin: Antioxidant Activity and Possible Therapeutical Role in Cutaneous Diseases
- Cutaneous toxicities of cancer therapy
- Runx1 Role in Epithelial and Cancer Cell Proliferation Implicates Lipid Metabolism and Scd1 and Soat1 Activity
- Profile analysis of adverse events after boron neutron capture therapy for head and neck cancer: a sub-analysis of the JHN002 study
- Role of 5α-reductase inhibitors in androgen-stimulated skin disorders.
- Cutaneous adverse effects of chemotherapy in cancer patients: A clinico epidemiological study
- Mucocutaneous Side Effects of Antineoplastic Drugs Used in Cancer Therapy in Erbil
- Differences in cell subsets between sun-exposed and unexposed skin: preliminary single-cell sequencing and biological analysis from a single case
- Germline Mutation in ATR in Autosomal- Dominant Oropharyngeal Cancer Syndrome
- Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil
- Safety of Whole-Body Abrogation of the TRF1 Shelterin Protein in Wild-Type and Cancer-Prone Mouse Models
- Signal integrator function of CXXC5 in Cancer
- Target-Adverse Events and Fear of Cancer Progression, Anxiety, and Depression in Patients with Advanced Non-Small Cell Lung Cancer
- Cutaneous Side Effects in Non-Small Cell Lung Cancer Patients Treated with Iressa (ZD1839), an Inhibitor of Epidermal Growth Factor
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- The semiotics of breast cancer: Signs, symptoms, and sales
- Chronic Toxicity Studies of the Potential Cancer Preventive 2-(Difluoromethyl)-<i>dl</i>-ornithine
- The Roles of the Lrig1- and Lgr6-Positive Stem Cells in the Skin and the Functions of the Molecular Markers That Define Them
- Accumulation of I131 by the skin and hair of animals and man
- Microneedles as transdermal drug delivery system for enhancing skin disease treatment